Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)

Jieun Park; Eun Sol Chang; Ji Yeon Kim; Chaithanya Chelakkot; Minjung Sung; Ji Young Song; Kyungsoo Jung; Ji Hye Lee; Jun Young Choi; Na Young Kim; Hyegyeong Lee; Mi Ran Kang; Mi Jeong Kwon; Young Kee Shin; Yeon Hee Park; Yoon La Choi

doi:10.1186/s13058-024-01952-0

Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)

Jieun Park
, Eun Sol Chang
, Ji Yeon Kim
, Chaithanya Chelakkot
, Minjung Sung
, Ji Young Song
, Kyungsoo Jung
, Ji Hye Lee
, Jun Young Choi
, Na Young Kim
, Hyegyeong Lee
, Mi Ran Kang
, Mi Jeong Kwon
, Young Kee Shin
, Yeon Hee Park
, Yoon La Choi

Seoul National University
Sungkyunkwan University
Genobio Corp.
Abion Inc.
LOGONE Bio Convergence Research Foundation
Gencurix, Inc.
Kyungpook National University

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Following the publication of the original article, the authors reported that an abbreviation in the Background section of the manuscript, specifically, in the fourth paragraph, was inaccurate. Mesenchymal-epithelial transition factor (MET). MET (MNNG-HOS transforming gene). The Original Article has been corrected.

Original language	English
Article number	3
Journal	Breast Cancer Research
Volume	27
Issue number	1
DOIs	https://doi.org/10.1186/s13058-024-01952-0
State	Published - Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/s13058-024-01952-0

Fingerprint

Dive into the research topics of 'Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)'. Together they form a unique fingerprint.

Cite this

Park, J., Chang, E. S., Kim, J. Y., Chelakkot, C., Sung, M., Song, J. Y., Jung, K., Lee, J. H., Choi, J. Y., Kim, N. Y., Lee, H., Kang, M. R., Kwon, M. J., Shin, Y. K., Park, Y. H., & Choi, Y. L. (2025). Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y). Breast Cancer Research, 27(1), Article 3. https://doi.org/10.1186/s13058-024-01952-0

@article{7674b23f6e7e4adcbce201824d909401,

title = "Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)",

abstract = "Following the publication of the original article, the authors reported that an abbreviation in the Background section of the manuscript, specifically, in the fourth paragraph, was inaccurate. Mesenchymal-epithelial transition factor (MET). MET (MNNG-HOS transforming gene). The Original Article has been corrected.",

author = "Jieun Park and Chang, \{Eun Sol\} and Kim, \{Ji Yeon\} and Chaithanya Chelakkot and Minjung Sung and Song, \{Ji Young\} and Kyungsoo Jung and Lee, \{Ji Hye\} and Choi, \{Jun Young\} and Kim, \{Na Young\} and Hyegyeong Lee and Kang, \{Mi Ran\} and Kwon, \{Mi Jeong\} and Shin, \{Young Kee\} and Park, \{Yeon Hee\} and Choi, \{Yoon La\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2025",

month = dec,

doi = "10.1186/s13058-024-01952-0",

language = "English",

volume = "27",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central Ltd",

number = "1",

}

Park, J, Chang, ES, Kim, JY, Chelakkot, C, Sung, M, Song, JY, Jung, K, Lee, JH, Choi, JY, Kim, NY, Lee, H, Kang, MR, Kwon, MJ, Shin, YK, Park, YH & Choi, YL 2025, 'Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)', Breast Cancer Research, vol. 27, no. 1, 3. https://doi.org/10.1186/s13058-024-01952-0

Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y). / Park, Jieun; Chang, Eun Sol; Kim, Ji Yeon et al.
In: Breast Cancer Research, Vol. 27, No. 1, 3, 12.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)

AU - Park, Jieun

AU - Chang, Eun Sol

AU - Kim, Ji Yeon

AU - Chelakkot, Chaithanya

AU - Sung, Minjung

AU - Song, Ji Young

AU - Jung, Kyungsoo

AU - Lee, Ji Hye

AU - Choi, Jun Young

AU - Kim, Na Young

AU - Lee, Hyegyeong

AU - Kang, Mi Ran

AU - Kwon, Mi Jeong

AU - Shin, Young Kee

AU - Park, Yeon Hee

AU - Choi, Yoon La

PY - 2025/12

Y1 - 2025/12

N2 - Following the publication of the original article, the authors reported that an abbreviation in the Background section of the manuscript, specifically, in the fourth paragraph, was inaccurate. Mesenchymal-epithelial transition factor (MET). MET (MNNG-HOS transforming gene). The Original Article has been corrected.

AB - Following the publication of the original article, the authors reported that an abbreviation in the Background section of the manuscript, specifically, in the fourth paragraph, was inaccurate. Mesenchymal-epithelial transition factor (MET). MET (MNNG-HOS transforming gene). The Original Article has been corrected.

UR - https://www.scopus.com/pages/publications/85215217175

U2 - 10.1186/s13058-024-01952-0

DO - 10.1186/s13058-024-01952-0

M3 - Comment/debate

C2 - 39773237

AN - SCOPUS:85215217175

SN - 1465-5411

VL - 27

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 1

M1 - 3

ER -

Park J, Chang ES, Kim JY, Chelakkot C, Sung M, Song JY et al. Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y). Breast Cancer Research. 2025 Dec;27(1):3. doi: 10.1186/s13058-024-01952-0

Correction to: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (Breast Cancer Research, (2024), 26, 1, (13), 10.1186/s13058-024-01768-y)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this